Metabolic syndrome and breast cancer risk: a case-cohort study nested in a multicentre italian cohort.
Metabolic syndrome and breast cancer risk: a case-cohort study nested in a multicentre italian cohort.
复制标题
DOI:
10.1371/journal.pone.0128891
复制
发表时间:
2015
期刊:
影响因子:
3.7
通讯作者:
Krogh V
中科院分区:
文献类型:
--
作者:
Agnoli C;Grioni S;Sieri S;Sacerdote C;Ricceri F;Tumino R;Frasca G;Pala V;Mattiello A;Chiodini P;Iacoviello L;De Curtis A;Panico S;Krogh V
Metabolic syndrome (defined as at least three among abdominal obesity, high blood triglycerides, low high-density lipoprotein cholesterol, high blood glucose, and high blood pressure) is emerging as a risk factor for breast cancer; however few studies – most confined to postmenopausal women – have investigated associations between breast cancer risk and metabolic syndrome. The purpose of this study was to examine the association between metabolic syndrome and its components, and risk of breast cancer in postmenopausal and premenopausal women. We performed a case-cohort study on 22,494 women recruited in 1993-1998 to four Italian centres (Turin, Varese, Naples, Ragusa) of the European Prospective Investigation into Cancer and Nutrition (EPIC) and followed-up for up to 15 years. A random subcohort of 565 women was obtained and 593 breast cancer cases were diagnosed. Hazard ratios (HR) with 95% confidence intervals (CI), adjusted for potential confounders, were estimated by Prentice-weighted Cox proportional hazards models. Presence of metabolic syndrome was associated with significantly increased breast cancer risk in all women (HR 1.52, 95%CI 1.14-2.02). When the analyses were repeated separately for menopausal status, the association was limited to postmenopausal women (HR 1.80, 95%CI 1.22-2.65) and absent in premenopausal women (HR 0.71, 95%CI 0.43-1.16); P for interaction between metabolic syndrome and menopausal status was 0.001. Of metabolic syndrome components, only high blood glucose was significantly associated with increased breast cancer risk in all women (HR 1.47, 95%CI 1.13-1.91) and postmenopausal women (HR 1.89, 95%CI 1.29-2.77), but not premenopausal women (HR 0.80, 95%CI 0.52-1.22; P interaction=0.004). These findings support previous data indicating that metabolic syndrome is an important risk factor for breast cancer in postmenopausal women, but not in premenopausal women, and suggest that prevention of metabolic syndrome through lifestyle changes could confer protection against breast cancer.
登录
查看更多内容
DOI:
10.1016/j.numecd.2009.02.006
发表时间:
2010-01
期刊:
Nutrition, metabolism, and cardiovascular diseases : NMCD
影响因子:
--
作者:
Agnoli C;Berrino F;Abagnato CA;Muti P;Panico S;Crosignani P;Krogh V
通讯作者:
Krogh V
DOI:
10.1158/1055-9965.epi-09-0235
发表时间:
2009-07
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
Kabat GC;Kim M;Chlebowski RT;Khandekar J;Ko MG;McTiernan A;Neuhouser ML;Parker DR;Shikany JM;Stefanick ML;Thomson CA;Rohan TE
通讯作者:
Rohan TE
影响因子:
4.7
作者:
Norat, T.;Dossus, L.;Kaaks, R.
通讯作者:
Kaaks, R.
影响因子:
4.9
作者:
McTernan, PG;Anwar, A;Kumar, S
通讯作者:
Kumar, S
影响因子:
3.8
作者:
Bosco, Jaclyn L. F.;Palmer, Julie R.;Boggs, Deborah A.;Hatch, Elizabeth E.;Rosenberg, Lynn
通讯作者:
Rosenberg, Lynn